Biossimilars, are they really cost saving? The case of recombinant human follicle stimulating hormone in Portugal

Category Primary study
JournalValue in Health
Year 2015
This article has no abstract
Epistemonikos ID: aec45811682f1891881057b032f6243e93e291a7
First added on: Feb 07, 2025